Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States. The company discover...
Q2 2026
Aug 11, 2026
Q1 2026
May 14, 2026
FY 2025
Feb 13, 2026
Q4 2025
Q3 2025
Nov 3, 2025
